ING GROEP NV
Position in CRL — Charles River Laboratories International, Inc.
CIK 1039765
AMSTERDAM, P7
Position in CRL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,343,050
+$248,193 QoQ
Shares Held
5,922
-6.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#221
of 569 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ING GROEP NV holds $198,923,237 across 9 Diagnostics & Research names. CRL ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
173,991 | $87,232,127 | |
| 2 | DHR |
Danaher Corp /De/
|
396,449 | $75,515,605 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
39,700 | $21,024,723 | |
| 4 | A |
Agilent Technologies, Inc.
|
34,746 | $4,615,311 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
20,522 | $3,965,260 | |
| 6 | DGX |
Quest Diagnostics Inc
|
17,294 | $3,665,463 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
This page
|
5,922 | $1,343,050 | |
| 8 | WAT |
Waters Corp /De/
|
2,154 | $807,836 |
All Filings in CRL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,343,050 | 5,922 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,094,857 | 6,347 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,268,692 | 6,360 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $995,398 | 6,362 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $980,630 | 6,463 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $982,895 | 6,530 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,205,622 | 6,531 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $1,360,077 | 6,905 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $1,432,012 | 6,932 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,904,507 | 7,029 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,660,237 | 7,023 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $1,261,523 | 6,437 | Shares | Defined | 2023-10-27 | |
| 2023-03-31 | $1,744,935 | 8,646 | Shares | Defined | 2023-05-09 | |
| 2022-09-30 | $1,568,889 | 7,972 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,045,553 | 9,560 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $2,273,463 | 8,006 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,481,849 | 6,587 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,746,006 | 4,231 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $1,526,659 | 4,127 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||